Acquisition / mergerNotable· Adverse for the businessFiled on BSE ·

Aster DM Quality Care converts INR 102.46 Cr subsidiary loan, to end DMERF agreements

Aster DM Healthcare · Healthcare Services

Arthneeti Research DeskPublished 1 min read
₹102 CrAcquisition / merger

Key highlights

  • Board approved converting INR 102.46 Cr loan to wholly owned subsidiary Sri Sainatha into 10,24,62,779 equity shares of INR 10 each; no change in the 100% holding.
  • Board approved ending the O&M Agreement (4 March 2016) and Medical Services Agreement (1 April 2026) with DMERF by mutual consent, subject to termination documents and settling dues.
  • Unit contributed 0.40% of the total revenue of the group; closure is meant to cut related party transactions with DMERF; expected completion date is given as 06 November 2026.

Why it's rated notable: order cancellation is always high

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Acquisition

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Aster DM Healthcare

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.